GAMMAGARD LIQUID / Immune Globulin Intravenous (Human) IVIG Now Available in USA for the Treatment of Primary Immunodeficiencies
Baxter Healthcare Corporation has recently announced the availability of their GAMMAGARD LIQUID (IVIG) 10% Solution for the treatment of primary immunodeficiencies to patients in the United States. The company is to restrict the use of its current product GAMMAGARD S/D to only those patients that require a low Immunoglobulin A (IgA) therapy.
Read More